Health and Healthcare

What Arcturus Therapeutics Brings to the Fight Against the Coronavirus

MarianVejcik / Getty Images

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stock jumped on Wednesday after the company announced that it would be joining the fight against the latest coronavirus. In terms of the specifics, Arcturus announced a partnership with Duke-NUS Medical School to develop a COVID-19 vaccine for Singapore.

The development of a COVID-19 vaccine will be based on Arcturus’s STARR technology and will take advantage of a unique platform developed at Duke-NUS allowing rapid screening of vaccines for effectiveness and safety.

Some quick background: the STARR Technology platform combines self-replicating RNA with LUNAR, a leading nanoparticle non-viral delivery system, to produce proteins inside the human body. Due to superior immune response and sustained protein expression, Arcturus’s STARR Technology is expected to produce a vaccine response at much lower doses compared to traditional mRNA vaccines.

Overall this platform could lead to the ability to treat many more people with a single GMP-manufactured production batch, thereby greatly increasing efficiency and reducing time required to produce sufficient quantities of vaccine for large populations.

Joseph Payne, president and CEO of Arcturus, commented:

We have observed STARR technology in pre-clinical models to be effective at extraordinarily low doses — greater than 30-fold more efficient than traditional mRNA.  The Arcturus manufacturing process has been applied in multiple large GMP batches of highly pure RNA in our LUNAR-OTC program.  If successful, Arcturus could develop a vaccine capable of vaccinating millions of people for a fraction of the cost of traditional mRNA vaccines.

Arcturus stock was last seen up about 19% at $17.21, in a 52-week range of $4.26 to $18.75. The consensus price target is $20.00.

It’s Your Money, Your Future—Own It (sponsor)

Retirement can be daunting, but it doesn’t need to be.

Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!

Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.